latest news releases from the newsroom
Encysive Pharmaceuticals Inc.
Encysive Pharmaceuticals Announces Launch of Thelin in Germany
HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for the treatment of pulmonary arterial hypertension (PAH). The Company received European Union marketing authorization for THELIN from the European Commission in August 2006. THELIN is the first selective endothelin A receptor antagonist and the first once-daily oral treatment available for patients with PAH.
Hydro's Oil and Gas activities to Merge With Statoil
OSLO, Norway, Dec. 18, 2006 (PRIME NEWSWIRE) -- The Board of Directors of Hydro and Statoil have agreed to recommend to their shareholders a merger of Hydro's oil and gas activities with Statoil, creating the world's largest offshore operator with a strengthened platform for future growth. The new company will have a combined production of 1.9 million barrels per day in 2007 and proven oil and gas reserves of 6.3 billion barrels of oil equivalents. Hydro will continue as a leading, focused global aluminium company.
Actelion Announces Successful Study With Tracleer(r) in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
ALLSCHWIL, Switzerland, Dec. 17, 2006 (PRIME NEWSWIRE) -- Actelion Ltd (SWX:ATLN), (Other OTC:ALIOF) announced today that initial results from the double-blind, placebo-controlled, multicenter study EARLY (Endothelin Antagonist Trial in miLdly Symptomatic PAH patients, NYHA modified functional class II) indicate that six months of treatment with the dual endothelin receptor antagonist bosentan (Tracleer(r)) showed a significant reduction in pulmonary vascular resistance, a strong trend towards improved exercise capacity and a significant delay in the time to clinical worsening.
Paradigm Spine, LLC
Paradigm Spine Receives CE Mark for Coflex-F Interspinous Fusion Device
NEW YORK, Dec. 18, 2006 (PRIME NEWSWIRE) -- Paradigm Spine, LLC, a developer of innovative posterior non-fusion spinal implant solutions, announced that it has received a European Union CE Mark for its coflex-F(tm). The CE Mark will allow Paradigm Spine to begin marketing the coflex-F(tm) in Europe and many countries around the world that recognize the certification.
Well Renewal, Inc.
Well Renewal Signs LOI to Acquire Oil Field Services Company
TULSA, Okla., Dec. 15, 2006 (PRIME NEWSWIRE) -- Well Renewal, Inc. (Pink Sheets:WRNW), a rapidly growing diversified oil and gas regional operator, specializing in enhanced recovery methods of abandoned and low-production oil properties, oil field services and petrochemical distribution, today announced it has signed a LOI to acquire Pro-Formance Oil Field Services, LLC. Well Renewal will utilize Pro-Formance's expertise and significant oil and gas field services equipment and existing servicing agreements to expand its rapidly growing oil field services division. Upon completion of due-diligence, the transaction is expected to close before year's end.